April 25, 2023 02:07 PM EDT
FDA+
Manufacturing

Sun Phar­ma tem­porar­i­ly halts ship­ments from man­u­fac­tur­ing plant af­ter FDA let­ter

Tyler Patchen

News Reporter

Sun Phar­ma is paus­ing pro­duc­tion at one of its plants in In­dia af­ter fac­ing scruti­ny by US reg­u­la­tors over nec­es­sary cor­rec­tive work.

In a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Mi­crosoft-backed Enve­da rais­es $130M for drugs in I&I, obe­si­ty and oth­er ar­eas

As­traZeneca culls Phase 2 opi­oid use dis­or­der drug

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times